Publication | Closed Access

Tacrolimus as monotherapy or combined with minidose methotrexate for graft-versus-host disease prophylaxis after allogeneic peripheral blood stem cell transplantation: long-term outcomes

Cell TherapyTransplantationMarrow TransplantationGraft-versus-host Disease ProphylaxisStem Cell TransplantationImmunologyMinidose MethotrexateImmunotherapyMedicineCell TransplantationLong-term OutcomesGraft Rejection